<DOC>
	<DOCNO>NCT00354666</DOCNO>
	<brief_summary>This study design test safety aspect effect lung function new dry powder version GSK159797 asthmatic subject inhale . This allow comparison previous study use inhalation drug vapour .</brief_summary>
	<brief_title>Single Doses GSK159797 On Patient Safety And Lung Function In Patients With Mild To Moderate Asthma</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Inclusion criterion : Subjects mild moderate stable asthma lung problem . Male subject females able get pregnant ( e.g . postmenopausal surgically sterile ) . Nonsmokers . Subjects show measurable improvement function lung single dose salbutamol . Exclusion criterion : Any significant illness . Subjects heart problem . Subjects cold chest infection 24 week prior study . Subjects take medication asthma , condition , compatible study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>inhale</keyword>
	<keyword>asthmatic subject</keyword>
	<keyword>GSK159797</keyword>
	<keyword>safety tolerability</keyword>
	<keyword>efficacy</keyword>
	<keyword>dry powder</keyword>
</DOC>